Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease.

The pharmacogenomics journal - 1 Jun 2010

Stone D J, Molony C, Suver C, Schadt E E, Potter W Z

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Alleles
Share to Alzheimer Disease
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers

Share to Clinical Trials, Phase II as Topic

Share to Cognition

Share to Disease Progression

Source

Identifiers

PMID: 19997085
DOI: 10.1038/tpj.2009.58

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease.PMID 19997085Read ↗

Apolipoprotein E genotyping in Alzheimer's disease. National Institute on Aging/Alzheimer's Association Working Group.Semantic proximity Read ↗

APOE genotyping and response to drug treatment in Alzheimer's disease.Semantic proximity Read ↗

Clinical implications of APOE genotyping for late-onset Alzheimer’s disease (LOAD) risk estimation: a review of the literatureSemantic proximity Read ↗

Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathway.Semantic proximity Read ↗

Apolipoprotein E genotype: utility in clinical practice in Alzheimer's disease.Semantic proximity Read ↗

Clinical application of apolipoprotein E genotyping to Alzheimer's diseaseSemantic proximity Read ↗

NIA/AIzA Conference on apolipoprotein E genotyping in Alzheimer's disease. Bibliography.Semantic proximity Read ↗

Allele predicted accelerated rate of cognitive decline in Alzheimer's disease.Semantic proximity Read ↗

The use of apolipoprotein E genotyping as a diagnostic test in suspected Alzheimer's disease.Semantic proximity Read ↗

APOE Genotype in the Era of Disease-Modifying Treatment With Monoclonal Antibodies Against Amyloid-β.Semantic proximity Read ↗

Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease.Semantic proximity Read ↗

APOE ɛ4 Allele Testing and Risk of Alzheimer Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.